-- PharmaCorp Rx(PCRX.V)週四宣布,已同意以2,420萬加元收購加拿大東部八家PharmaChoice Canada旗下的藥局。 聲明稱,此次收購將使用現有現金進行融資,並擴大了PharmaCorp的業務版圖和營運規模。所有門市將繼續由其現有藥劑師管理。 預計收購將在60天內完成。 PharmaCorp也簽署了不具約束力的意向書,擬收購四家Morel藥局。如果收購完成,預計將在未來兩個季度內完成。 執行主席Alan Simpson表示:「此次收購體現了我們持續推進收購策略以及強大的採購網絡。」「這些門市專注於重要的城市市場,加上經驗豐富的藥劑師團隊的持續穩定,使我們能夠在保持強大的本地關係和卓越運營業績的同時,高效地進行整合。我們看到我們越來越多的收購機會,並且能夠儘早實現價值的價值 PharmaCorp 股票在多倫多證券交易所創業板收盤上漲 0.07 加元,至 0.50 加幣。
Related Articles
Shanghai International Airport's Q1 Profit Rises 11%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in the first quarter rose 11% to 577.8 million yuan from the year-ago attributable profit of almost 519.0 million yuan, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 10% year on year to 0.23 yuan from 0.21 yuan.Operating revenue inched 0.8% higher to 3.20 billion yuan from 3.17 billion yuan in the preceding year.
Shanghai International Airport's 2025 Profit Rises 10%, Revenue Climbs 8%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in 2025 rose 9.5% to 2.12 billion yuan from 1.93 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 9% year on year to 0.85 yuan from 0.78 yuan.Operating revenue gained 7.9% to 13.35 billion yuan from 12.37 billion yuan in the previous year.
ResMed CFO to Retire
ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.